introduction
The products in the medical and beauty industry are the king, and the track that can produce popular products is a good track.
This report focuses on the analysis of four potential sub circuits: hyaluronic acid, regenerative preparations, botulinum toxin and weight management. The market space is broad. The competition pattern of some circuits is still a blue ocean, and billions of heavy products may be born in the future.
A good company is one that has strong BD capability, can quickly introduce advantageous products, and can successfully realize cash by virtue of excellent promotion and sales ability.
Compared with medicine, Yimei has stronger consumption attributes and faster product change. Therefore, for Yimei product companies, relying on self-research can not achieve the continuous output of popular products. It is the key to have strong BD ability to quickly layout the blue ocean track or introduce differentiated products.
Starting from the subdivided track, this report analyzes in detail the competition pattern of the current popular track, future product R & D ideas, market space, etc., and looks for potential POP products that may become the next “Hi body”; Horizontal analysis of the product layout of Yimei company, combined with various BD cooperation projects and product promotion, to explore the high-quality targets that may become the next “aierjian”.
Focus on the subject: Huadong Medicine Co.Ltd(000963) (000963. SZ), Imeik Technology Development Co.Ltd(300896) (300896. SZ), Jiangsu Sihuan Bioengineering Co.Ltd(000518) (000518. SZ), Shanghai Haohai Biological Technology Co.Ltd(688366) (688366. SH).
